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Abstract
Background: Cluster randomised trials (CRTs) are a key instrument to evaluate public health interventions, particularly in
low- and middle-income countries (LMICs). Fidelity assessment examines study processes to gauge whether an
intervention was delivered as initially planned. Evaluation of implementation fidelity (IF) is required to establish
whether the measured effects of a trial are due to the intervention itself and may be particularly important for
CRTs of complex interventions. Current CRT reporting guidelines offer no guidance on IF assessment. We will
systematically review the scientific literature to study current practices concerning the assessment of IF in CRTs of
public health interventions in LMICs.
Methods: We will include CRTs of public health interventions in LMICs that planned or assessed IF in either the trial
protocol or the main trial report (or an associated document). Search strategies use Medical Subject Headings (MESH)
and text words related to CRTs, developing countries, and public health interventions. The electronic database search
was developed first for MEDLINE and adapted for the following databases: EMBASE, CINAHL, PubMed, and EMB
Reviews, to identify CRT reports in English, Spanish, or French published on or after January 1, 2012. To ensure
availability of a study protocol, we will include CRTs reporting a registration number in the abstract. For each
included study, we will compare planned versus reported assessment of IF, and consider the dimensions of IF
studied, and data collection methods used to evaluate each dimension. Data will be synthesised using quantitative and
narrative techniques. Risk of bias for individual studies will be assessed using the Cochrane Collaboration Risk of Bias
Tool criteria and additional criteria related to CRT methods. We will investigate possible sources of heterogeneity by
performing subgroup analysis. This review was not eligible for inclusion in the PROSPERO registry.
Discussion: Fidelity assessment may be a key tool for making studies more reliable, internally valid, and externally
generalizable. This review will provide a portrait of current practices related to the assessment of intervention
fidelity in CRTs and offer suggestions for improvement. Results will be relevant to researchers, those who finance
health interventions, and for decision-makers who seek the best evidence on public health interventions.
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Developing countries, Systematic review protocol
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Introduction
As evidenced by their growing presence in the scientific
literature [1, 2], cluster randomised trials (CRTs) have
become a key instrument to evaluate public health inter-
ventions [1, 3–7], particularly in low- and middle-income
countries (LMICs) [3, 8]. Randomised controlled trials
(RCTs) are widely considered to provide the highest quality
of evidence on the effectiveness of health interventions
[9–12], and CRTs are a form of randomised trial in
which clusters of individuals (such as families, villages,
hospital services, or schools) rather than independent indi-
viduals are randomly allocated to intervention or control
groups [2]. Increasingly, public health researchers recognize
the importance of developing health interventions that are
directed not only to individuals but also to populations,
communities, and a wide range of social and environmental
factors influencing health [13, 14]. CRTs offer an appropri-
ate design to assess such public health interventions and
also to measure the overall effect of an intervention at the
population level [3, 5, 8, 13, 15], heterogeneity of impact
among population subgroups, and equity [16, 17].
Implementation fidelity in CRTs of public health
interventions
Although the scientific debate is ongoing [18], randomised
trials are generally viewed as the gold standard for estab-
lishing evidence of intervention effectiveness. Despite this,
the use of CRTs to evaluate public health interventions
raises unique methodological challenges. Recent systematic
reviews of CRT methods have found evidence of improve-
ments in the design and analysis of CRTs while noting defi-
ciencies in trial implementation that may compromise their
validity [19, 20]. Previous systematic reviews have empha-
sised the importance of process evaluation to mitigate these
methodological problems, which can affect the internal and
external validity of trial results [3, 19, 21–23].
“Implementation fidelity” refers to the degree to which
an intervention is delivered as initially planned [24]. Fi-
delity assessment is an aspect of process evaluation that
aims to understand and measure to what extent the
intervention is being implemented as intended, with a
view to clarifying relationships between intervention and
its intended outcomes, and learning what specific reasons
have caused the success or failure of the intervention
[9, 24, 25]. Evaluation of implementation fidelity within
trials has multiple benefits, which may include in-
creased confidence in scientific findings, increased
power to control for confounding factors and detect
intervention effects, and increased ability to evaluate
the performance of an intervention based on theory
[26]. Several studies have found that interventions im-
plemented with high fidelity achieved better results in
comparison with low-fidelity interventions [27–33]. Fi-
delity assessment can improve the internal and external
validity of CRTs [19] by providing evidence that the trial
results are due to the intervention itself rather than to
confounding variables and facilitating generalization of
results to contexts that may differ substantially from
the original trial setting [9, 24]. Fidelity assessment may
be particularly important for trials of public health in-
terventions, as these interventions tend to be complex
and constituted by multiple components [10, 34] that
may act independently or interdependently [35], lead-
ing to a greater potential for variation during imple-
mentation [24].
Framework for the evaluation of implementation fidelity
used in this review
Table 1 outlines the conceptual framework for evaluation
of implementation fidelity used in this review. The frame-
work is based principally on the work by Carroll et al. [24]
and includes elements of implementation fidelity and mod-
erating factors that may affect the delivery process. The
framework was further refined by Hasson, who expanded
the list of moderating factors considered in the framework
[36]. We selected this framework to guide the review
because it provides a comprehensive synthesis of pre-
vious work on implementation fidelity and has been
widely influential.
Fidelity assessment in CRT reporting guidelines
The Consolidated Standards of Reporting Trials
(CONSORT) group was created to provide guidance
to improve the quality and transparency of reporting
of RCTs [37]. The CONSORT Statement offers a
checklist of essential items that should be included
in reporting a RCT [37]. Due to the increasing use
of CRT designs, the CONSORT group proposed a
version of the CONSORT Statement for the report-
ing of cluster randomised trials in 2004 and updated
these guidelines in 2012 [2, 38].
The CONSORT Statement recognises that the trial
protocol for a given study may not have been followed
fully for some trial participants for a wide variety of rea-
sons, including failure to receive the entire intervention
as planned [37]. Cases of protocol nonadherence may in-
fluence the interpretation and credibility of the results
and thus the validity of the conclusions [19, 26, 39, 40].
To preserve the ability to make strong inferences about
the intervention effect, CONSORT offers recommenda-
tions on how issues of nonadherence should be handled
at the level of analysis. Specifically, it recommends that
all participants randomised be retained in the analysis
and analysed according to their original assigned groups,
an approach known as “intention-to-treat” or “ITT” ana-
lysis. This approach ignores noncompliance, protocol de-
viations, and anything that occurs after randomisation.
The rationale for the ITT approach is that random
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allocation procedures avoid bias when assigning interven-
tions to trial participants and thus facilitate causal infer-
ence. Any exclusion of patients from the analysis risks
compromising the randomisation and may lead to biased
results. This ITT approach can be contrasted with a “per
protocol” or “PP” analysis, which restricts the analysis to
participants who fulfil the protocol in terms of eligibility,
interventions, and outcome assessment [19, 26, 39, 40].
According to the CONSORT, although a PP analysis may
be appropriate in some instances, due to the exclusion of
participants, it should be considered as a non-randomised,
observational comparison.
The CONSORT guidance on handling protocol nonad-
herence has been primarily developed in relation to
individually randomised parallel group trials. However, rea-
sons for protocol nonadherence in individually randomised
RCTs may differ from those in CRTs. In a clinical trial set-
ting, nonadherence depends largely on the actions of the
trial participant (e.g. failure to adhere to therapy) and the
treatment provider (e.g. failure to follow treatment
protocol), which may in turn be related to issues such
as treatment side effects and safety. In CRTs of public
health interventions, protocol nonadherence may occur
because complex interventions that include multiple
components are delivered with poor fidelity. However,
despite the scientific importance of protocol nonadher-
ence, the current CONSORT guidelines for individually
randomised parallel group trials [37] and CRTs [2, 38]
offer no advice on the methods to assess its occurrence
during the course of a trial.
Rationale for undertaking this review
LMIC governments and other development partners
have strengthened research and intervention efforts to
support the UN Millennium Development Goals
(MDGs) and Sustainable Development Goals (SDGs)
agenda. As the global community intensifies the
search for the best evidence on public health interven-
tions to improve health and development outcomes in
LMICs, CRTs have become an essential tool. Policy-
makers are interested in using the best available evi-
dence to make decisions about the effectiveness of
specific interventions in LMICs facing considerable
budget constraints. Although CRTs have been widely
implemented to evaluate public health interventions
in both high-income countries and LMICs, country
context, interventions, approaches, and outcomes may
differ substantially between settings. We therefore
limit our focus to LMICs.
As earlier methodologically-oriented systematic re-
views have demonstrated, CRTs of complex public
health interventions may be particularly at risk of
experiencing protocol deviations and nonadherence,
and these may compromise the validity of their findings
[19, 20]. Although process evaluation techniques such as
evaluation of implementation fidelity can help to assess
the extent of these problems and mitigate their negative
effects, current reporting guidelines for CRTs offer no
specific guidance on the assessment of intervention
fidelity within CRTs. Wide divergence in current practices
is therefore likely. We will undertake a methodologically-
oriented systematic review of current practices related to
the assessment of intervention fidelity within CRTs of
public health interventions in LMICs, with a view to
informing the best practices for these CRTs. To our know-
ledge, no other systematic review has been conducted on
this question.
Table 1 Conceptual framework for implementation fidelity used
in this review
Fidelity components
Content Defined as an attempt to establish the
“active ingredients” of the intervention,
for example, in a theory of change or
logic model, and assess whether they
have been delivered as planned
Coverage Refers to the degree to which all persons
who met study inclusion criteria received
the intervention
Frequency Refers to whether the intervention was
delivered with the regularity or frequency
planned by its designers.
Duration Establishes whether the intervention was





Factors such as the degree of intervention
complexity and whether the intervention
description is complete or incomplete,




Several support strategies may be used to
optimise and to standardise implementation
fidelity.
Quality of delivery Concerns whether an intervention is
delivered in a way that increases the
likelihood of achieving the desired
health outcomes
Participant responsiveness Intervention uptake depends on its
acceptance by and acceptability to those
receiving it. Low participant involvement
or responsiveness may negatively impact
intervention fidelity.
Recruitmenta Refers to procedures that were used to
attract potential programme participants.
Contexta Refers to the surrounding social systems,
such as structures and cultures of
organizations and groups, and historical
and concurrent activities and events
Adapted from Carrol et al. [24]
aThese components were added by Hasson [36]
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Objective
We will conduct a systematic review of the published
scientific literature to study current practices concern-
ing the assessment of intervention fidelity in CRTs of
public health interventions in LMICs.
This review will address the following research questions:
1. Based on information from the trial registry (and the
published study protocol, if applicable): What
proportion of recent CRTs of public health
interventions in LMICs planned to assess
implementation fidelity (IF)?
2. Based on information from the published trial report
(or a complementary document such as a published
article, a grey literature report, or an online appendix
reporting the assessment of IF), what proportion of
recent CRTs of public health interventions in LMICs
reported assessing IF?
3. For those studies that assessed IF, which fidelity
components were examined, and which data
collection methods were employed to assess each
component?
4. Is there evidence of divergent practices between
planned and reported studies, or of outcome
reporting bias related to the assessment of IF?
a. Based on comparison of the results of questions
1 and 2, what is the overall agreement between
planned and reported assessment of IF?
b. Are trial reports with negative findings for
the ITT analysis more likely to report a PP
analysis?
c. For the subset of studies that included both ITT
and PP analyses, what is the overall agreement
between ITT and PP analyses concerning the
intervention’s effectiveness?
d. Does the magnitude of the intervention effect
differ for PP as compared to ITT analyses?
To answer our research questions, we will first identify
all CRTs from 2012 onwards of public health interven-
tions conducted in LMICs with an available study proto-
col registered in a public trial registry. A given CRT will
be included in the review if the protocol, the trial report,
or both address IF. For each CRT included in the review,
we will compare planned assessment methods for IF as
described in the trial registry (and published study
protocol, if applicable) with published methods and re-
sults from the main trial report (and related docu-
ments, if relevant). We will use a variety of measures to
summarise the results.
Methods
We describe the study methods in seven steps adapted
from the 2015 Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA)-P reporting
guidelines for systematic reviews and meta-analysis proto-
cols [41]. The PRISMA-P checklist is provided as an add-
itional file (see Additional file 1). As this review focuses on
methodological issues rather than on health-related out-
comes, it was not eligible for inclusion in the PROSPERO
registry [42]. In the event of protocol amendments, we
will provide the date of each amendment, a description of
the change, and the rationale for the change.
Eligibility criteria
Studies will be selected from the peer-reviewed scientific
literature according to the following study and report
characteristics.
Study characteristics
Study designs We will include all CRTs. For the purposes
of this review, a CRT is defined as a trial in which intact
social units or clusters of individuals, rather than inde-
pendent individuals, are randomly allocated to inter-
vention groups [38]. CRTs may include trials employing
parallel group, stepped wedge, or factorial designs; clus-
ter randomised adaptive trials; and cluster randomised
pragmatic trials, among others. CRTs with an adaptive
design allow modifications based on data accumulated
following trial start, while preserving the integrity of
the trial [37]. Pragmatic trials are designed to evaluate
the efficacy of an intervention in routine clinical practice
in order to maximise applicability and generalizability of
the results of the study [43, 44].
Participants Study participants will be human adults
or children living in LMICs. LMICs will be defined
according to the 2016 World Bank country classifica-
tions [45].
Interventions This review focuses on “public health in-
terventions”. We employ the definition of “public health”
proposed in the World Health Organization (WHO)
health promotion glossary as “The science and art of
promoting health, preventing disease, and prolonging life
through the organized efforts of society” [46]. Adapting
the definition proposed by Rychetnik and colleagues, we
define a public health intervention as a disease preven-
tion or health promotion intervention applied to many,
most, or all members in a community, which aims to de-
liver a net benefit to the community or population, as
well as benefits to individuals [47, 48]. Public health in-
terventions are distinguished from clinical interventions
aimed at preventing or treating diseases at the individual
level [47, 48].
In order to operationalise this definition and guide se-
lection of specific studies, we will use the “Intervention
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Wheel”, a graphic model of population-based public
health practice illustrated with specific examples, de-
veloped by the Minnesota Department of Health [49].
The intervention wheel provides 17 public health in-
terventions, selected to meet five criteria. To be con-
sidered as public health interventions, interventions
should as follows: (i) focus on entire populations (or
particular subgroups within a population), (ii) be grounded
in an assessment of community health, (iii) consider the
broad determinants of health, (iv) emphasise health promo-
tion and prevention, and (v) intervene at multiple levels
[49]. We used these five criteria to aid in decisions concern-
ing study inclusion.
According to Rychetnik and colleagues, public health
interventions are inherently “complex, programmatic,
and context dependent” and these characteristics raise
challenges for their evaluation [47]. The assessment of
intervention fidelity may be especially important for
public health interventions, and this consideration un-
derlies our choice to focus on them in this review.
Comparators Comparators will be defined as planned
per the original CRT. Given the nature of public health
interventions and the pragmatic orientation of CRTs in
LMICs, we anticipate that a large proportion of studies
included in the review will define the comparison group
as receiving the “usual care”.
Outcomes The focus of this methodologically-oriented
review is on comparisons of planned and reported out-
comes related to IF. For studies that assessed IF in either
the trial protocol or the main trial report, we will include
both the study protocol and the main trial report.
Recognising that word limits for scientific journal articles
are highly constrained and that the current CONSORT
reporting guidelines for CRTs do not require description
of elements related to IF, we also decided to include CRTs
reporting the assessment of IF in a complementary docu-
ment such as a published article, an online appendix to
the main paper, or a grey literature report, in lieu of
reporting the assessment of IF in the main trial report.
These elements will be verified by checking the bibliog-
raphy for the main trial report and additional sources.
For the purposes of study selection, we considered
that studies evaluated IF if they either proposed
methods to assess or reported results related to the
evaluation of at least one of the four key fidelity com-
ponents: (1) content, (2) coverage, (3) frequency, and
(4) duration. For CRTs taking an adaptive approach,
we will consider if these trials respect pre-established
decision rules regarding changes to their design. In
addition, we will include all CRTs that reported a per-
protocol analysis.
Report characteristics
Setting Eligible studies will be implemented in LMICs
as classified by the World Bank [45].
Availability of the study protocol To ensure availabil-
ity of a study protocol, we will include CRTs report-
ing a registration number in the abstract for any
trial registry meeting the WHO criteria [50]. The
WHO trial registration data set (TRDS) is an inter-
nationally agreed-upon set of items that provide in-
formation on the design, conduct, and administration of
clinical trials. The WHO International Clinical Trials
Registry Platform (ICTRP) facilitates the publication
of the TRDS on a publicly accessible website, through
a network of partner registries that have agreed to
adopt the TRDS as a common standard. The TRDS
will be used in this review to evaluate planned assess-
ment of intervention fidelity, either alone, or in con-
junction with a published study protocol. TRDS field
20 “Key secondary outcomes” is particularly pertinent
for this assessment.
Publication dates We will include studies for which the
main trial report was published on or after January 1,
2012. We chose this date because the last update of the
CONSORT Statement to improve reporting of CRTs was
published in 2012, and we wanted to analyse current
practices. No restriction will be applied to the publica-
tion date for the protocol.
Language We will include studies published in English,
Spanish, or French, which are languages known by the
research team.
Exclusion criteria We will exclude studies that are (i)
not cluster randomised trials, studies that (ii) do not
plan or report the assessment of IF and (iii) are not
public health interventions, (iv) conducted in a high-
income country as defined by the World Bank 2016
country classification [45], (v) are published before 2012,
(vi) do not have a publicly available protocol for com-
parison, or (vii) for which only the protocol but not the
main trial report has been published. Manuscripts will
be also excluded if they are (viii) pilot studies, (ix) sec-
ondary reports of a main study for which the relevant find-
ings were published prior to 2012, (x) studies published
in a language other than English, Spanish, or French, or
(xi) studies from the grey literature.
Information sources and search strategy
Literature search strategies were developed in collabor-
ation with an academic librarian experienced in con-
ducting systematic review searches. Search strategies
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use Medical Subject Headings (MESH) and text words
related to cluster randomised trials, developing coun-
tries, and public health interventions. The electronic
database search was developed first for MEDLINE
(Ovid) (for the full search strategies, see Additional file
2) and then adapted for the following electronic data-
bases: EMBASE (Ovid), CINAHL (Ovid), PubMed, and
EMB Reviews (Ovid). Search terms are a combination
of “cluster-randomized”, “cluster analysis”, “health pro-
gram”, “public health service”, “health education”, “public
health”, “health promotion”, “health behavior”, “health
knowledge/attitudes practice”, “Preventive health services”,
“health care system”, “health education”, and “developing
countries”. The search strategy will span the time period
from January 2012 to May 2016 and will be updated to-
wards the end of the review. Searches will be filtered to arti-
cles concerning humans and written in English, French, or
Spanish. To augment this list, we will add relevant
studies suggested by members of the systematic re-
view team. Identified records will be uploaded into
the EndNote reference management software (version
X7.5.3, Thompson Reuters, 2016), and duplicates will
be eliminated.
Study screening and selection
Study screening and selection will be done manually
within the EndNote based on the inclusion and exclu-
sion criteria for this systematic review. To ensure the
availability of study protocols, we will limit the search
to CRTs that have the word stem “regist*” in the ab-
stract and use these results to begin the process of
screening and selection. We validated this procedure
by examining a subset of excluded articles. Screening
and selection will be done in two stages by two inde-
pendent reviewers (MCP and NM). In the first stage,
reviewers will independently screen the titles and
abstracts of each identified reference against the in-
clusion criteria to eliminate irrelevant publications. In
the second stage, we will screen the full text of all
studies that appear to meet the inclusion criteria or
for which there is uncertainty as to eligibility. For
each study, we will identify additional articles of po-
tential relevance, such as a published protocol or a
process evaluation, by reviewing references from the
main trial report, consulting the trial registry record,
and searching the PubMed database for new publica-
tions by the lead trial author. To aid in article screen-
ing and selection, the team will develop and test a
screening sheet for full-text review. Any disagreement
between reviewers will be resolved through discussion
and, as necessary, through arbitration by a third
author (MJ). The process of study selection will be
documented in a flow diagram describing studies
identified and excluded at each stage. We will also
provide a summary table describing studies excluded
at the stage of full-text review, along with reasons for
their exclusion.
Outcomes and prioritisation
The search and selection process for this review is de-
signed to identify two quantities required for calculation
of outcomes based on proportions: (1) numerator: These
are studies that meet all the inclusion and exclusion cri-
teria. As for all systematic reviews, these studies are our
principal focus and will be included in the review and
given detailed analysis. (2) Denominator: This is the total
N for the study, which we defined as all studies that
satisfy all the inclusion and exclusion criteria, with the
exception of the outcome criterion (planned or reported
IF assessment). It is essentially the universe of cluster
randomised trials of public health interventions in LMICs.
Both quantities will be clearly indicated in the study flow
diagram.
Primary outcome
The primary outcome for this study will be the pro-
portion of overall agreement between the protocol
and trial report concerning occurrence of IF assess-
ment. This corresponds to research question 4a.
Data will be summarised in a two-by-two table
comparing the assessment of intervention fidelity in
the trial report to that in the protocol. N represents
the set of recent CRTs of public health interventions
in LMICs that have registered the study protocol in a
publicly availably trial registry. For each CRT in N,
we will determine whether IF was assessed in the reg-
istered (or published) protocol or in the trial report
(or associated documents). Studies judged to have
assessed IF will be coded as “1”; others will be coded
as “0”. Judgements will represent reviewer consensus
(MCP and NM, with appeal to MJ in case of diver-
gences). The proportion of overall agreement is de-
fined as the proportion of eligible CRTs for which
judgements concerning the occurrence of implemen-
tation fidelity assessment agree in the protocol and in
the trial report (i.e. both positive or both negative). It
will be computed as (a + d)/N.
Protocol
+ −
Trial report + a b a + b
− c d c + d
a + c b + d N
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Secondary outcomes
To address research questions 1, 2, and 3, we will also
calculate the following:
 The frequency and proportion of trial protocols
reporting the assessment of intervention fidelity, out
of N
 The frequency and proportion of trial reports reporting
the assessment of intervention fidelity, out of N
 The proportion of positive agreement among those
that agree, computed as a/(a + d)
 The frequency counts and percentages summarising
fidelity components examined and data collection
methods proposed or employed
To address research question 4b, for all studies in-
cluded in the trial, we will also record the authors’ judg-
ments as to whether the intervention was effective.
Studies that concluded that the intervention is more ef-
fective than the control will be coded as “1”; studies that
were unable to reject the null hypothesis that there are
no significant differences between groups will be coded
as “0”. We will calculate as follows:
 The conditional probability that a PP analysis is
performed given that the ITT analysis shows no
difference between groups.
 The conditional probability that a PP analysis is
performed given that the ITT analysis shows a
positive intervention effect.
These measures will be calculated using a standard
formula for conditional probabilities:
Ρ ΒjΑð Þ ¼ Ρ Α and Βð Þ
Ρ Αð Þ
To address research questions 4c and 4d, we will
examine the subset of trial reports containing both ITT
and PP analyses. For studies comparing several interven-
tions (e.g. factorial design), data on each intervention
will be extracted separately.
To address research question 4c, we will study the pro-
portion of the overall agreement between the ITT and PP
analyses concerning intervention effectiveness.
Data will be summarised in a two-by-two table compar-
ing the assessment of intervention effectiveness in the ITT
analysis to that in the PP (intervention fidelity) analysis. T
is the total number of included CRTs reporting both an
ITT and PP analysis. Studies that concluded in favour of
the intervention group will be coded as “1”; those that are
unable to reject the null hypothesis that there is no signifi-
cant difference between groups will be coded as “0”. Judge-
ments will represent reviewer consensus (MCP and NM,
with appeal to MJ in case of divergences). The proportion
of overall agreement is defined as the proportion trial re-
ports for which judgements concerning intervention effect-
iveness agree in ITT and PP analyses (i.e. both positive
(favour the intervention group) or both negative (unable to
reject the null hypothesis of no difference between groups)).
It will be computed as (w + z)/T.
We will also calculate
 The frequency and proportion of ITT analyses that
conclude in favour of the intervention, out of T
 The frequency and proportion of PP analyses that
conclude in favour of the intervention, out of T
To address research question 4d, we will compare
intervention effect sizes reported for ITT and PP ana-
lyses. Comparisons will be summarised as the percentage
change in effect size, computed as the effect size for the
PP analysis/effect size for the ITT analysis *100.
Risk of bias in individual studies
To assess possible risk of bias for included studies, we will
use the Cochrane Collaboration tool to assess the risk of
bias in randomised trials [51] based on the following fac-
tors: random sequence generation, allocation concealment,
blinding of participants and personnel, blinding of outcome
assessment, incomplete outcome data, selective reporting,
and other sources of bias. Because the Cochrane Collabor-
ation tool was developed for individually randomised stud-
ies whereas our study focuses on CRTs, we will also include
several additional criteria specifically relevant to assessing
risk of bias in CRTs, recommended by the Cochrane
Collaboration [51] and other key sources [51–53].
These additional criteria will consider issues related to
the following: recruitment bias (potential for participant
self-selection to occur if individuals are recruited to the
trial after the clusters have been randomised); baseline
imbalances (because CRTs generally randomise a lim-
ited number of clusters, chance imbalances may affect
comparability of intervention and control groups); loss
of clusters (complete clusters may sometimes be lost
from a trial and thus be omitted from the analysis;
these missing data may lead to biased outcome assess-
ments); and unit of analysis (failure to properly account
ITT analysis
+ −
PP analysis + w x w + x
− y z y + z
w + y x + z T
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for clustering in the analysis) [51]. For each domain or
criterion of interest, we will assess each criterion as low
risk, high risk, or uncertain risk and provide a sample
text that illustrates the reasons for this judgement. This
evaluation will be done independently by two reviewers
(MCP and NM). Disagreements between reviewers will
be resolved by consensus or, if consensus cannot be
achieved, by consulting a third reviewer (MJ). Judge-
ments related to risk of bias will be summarised graph-
ically using RevMan 5.1 [51]. Risk of bias assessments
will be used to create categories of high-, uncertain-,
and low-risk studies to be used in subgroup analyses.
Systematic reviews of health outcomes often assess the
quality of a body of evidence using standardised tools
such as the GRADE system [54]. However, as this review
focuses on methodological issues rather than on health-
related outcomes, we will not use this tool.
Data extraction and data items
Two review authors will extract data independently
(MCP and NM). From each study protocol and trial report,
reviewers will extract data on (i) the study characteristics
(study location, aims, intervention); (ii) all applicable de-
scriptors of the CRT trial design (for example, parallel
group, stepped wedge, factorial, adaptive, pragmatic); (iii)
concepts related to the assessment of IF (assessment of fidel-
ity reported in protocol and/or main study, fidelity compo-
nents and moderating factors evaluated, data collection
methods, and any dimension used by the authors to evaluate
intervention fidelity distinct from those proposed by Caroll
and Hasson [24, 32]); (iv) whether events taking place in the
control group were monitored, as these can influence the ef-
fectiveness of the intervention [27, 55, 56]; and (v) informa-
tion for assessing the risk of bias of included studies. We
will also extract (vi) statistical results concerning the inter-
vention effectiveness and the authors’ qualitative conclusions
regarding the intervention effect for the primary (generally,
ITT) analysis and one or more subgroup analyses relevant
for intervention fidelity (generally, the PP analysis). If studies
investigate more than one intervention, we will extract data
relevant for each comparison. To reduce bias and errors in
data extraction, reviewers will use a pre-defined template
pilot tested on a subset of studies and a guide for data ex-
traction. To ensure consistency, reviewers will receive train-
ing prior to commencing extraction for the review and
undertake calibration exercises. Reviewers will resolve dis-
agreements by discussion and by appeal to a third author
(MJ) where necessary. All data extraction tools will be avail-
able as online supplementary documents.
Data synthesis
Results will be presented in accordance with the PRISMA
Statement [41]. A narrative synthesis will be provided, with
information presented in tables to summarise key data. The
narrative synthesis will explore relationships and findings
within and between the included studies. It will highlight
the four key dimensions of intervention fidelity identified
from the literature (content, coverage, frequency, and
duration), moderating factors for intervention fidelity
(participant responsiveness, comprehensiveness of policy,
strategies to facilitate implementation, quality of delivery,
recruitment, and context), any new dimensions explored,
and data collection method used to evaluate each key
dimension.
We will present quantitative data for all primary and
secondary outcomes proposed. Where appropriate, data
will be presented in tabular form.
We will investigate the possible sources of heterogeneity
by performing subgroup analysis. Specifically, we will re-
compute the main quantitative outcomes for subgroups of
studies with high, uncertain, and low risk of bias to better
understand potential sources of variation in results. If the
data permit, we will conduct a sensitivity analysis to explore
whether studies at lower risk of bias undertake more com-
prehensive assessment of intervention fidelity. Because of
the study question and the nature of the outcomes assessed,
we do not intend to perform meta-analyses.
Planned assessment of meta-biases
We recognize that data may be biased due to non-study-
related processes and plan to assess specific meta-biases.
This study compares results for protocols and published
trial reports, and is thus designed to address potential
reporting bias and to investigate potential outcome bias.
As our review focuses on methodological issues rather
than on outcome assessment, we will not assess poten-
tial publication bias.
Discussion
Development initiatives require high-quality evaluations
to determine whether the programmes work or not and
to know how to improve them [57, 58]. According to
Rychetnik et al. [48], evaluation of public health inter-
ventions requires detailed information about the “design
and implementation of an intervention; contextual cir-
cumstances in which the intervention was implemented;
and how the intervention was received”.
We will conduct a methodological systematic review to
evaluate the current practices for evaluating implementa-
tion fidelity in CRTs of public health interventions carried
out in LMICs. Fidelity assessment may be a key tool for
making studies more reliable, internally valid, and exter-
nally generalizable [59]. In the absence of fidelity assess-
ment, it may be difficult to determine if CRT results are
due to the intervention design, to its implementation, or
to unknown or external factors that may influence results.
The rejection of effective interventions or acceptance of
ineffective interventions incurs incalculable costs, due to
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the use of financial and scientific resources, and the inabil-
ity of the authors to extrapolate the results [26]. Improved
assessment and reporting of intervention fidelity may be
important for researchers, for those who finance health in-
terventions, and for decision-makers who seek the best
evidence on public health interventions to promote health,
prevent disease, and reduce health inequalities.
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